Skip to Content

973 (Divalproex Sodium Delayed-Release 125 mg)

Pill with imprint 973 is White, Round and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Wockhardt USA.

Divalproex sodium is used in the treatment of bipolar disorder; epilepsy; mania; migraine prevention; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 973

Divalproex Sodium Delayed-Release

Imprint:
973
Strength:
125 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Wockhardt USA
Inactive Ingredients:
silicon dioxide
microcrystalline cellulose
corn starch
povidone
croscarmellose sodium
glyceryl behenate
magnesium silicate
hypromelloses
polyethylene glycol
polyvinyl alcohol
polysorbate 80
methacrylic acid - ethyl acrylate copolymer (1:1) type a
triethyl citrate
sodium bicarbonate
sodium lauryl sulfate
dimethicone
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide